Antipodes Partners LTD Qiagen N.V. Transaction History
Antipodes Partners LTD
- $2.83 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding QGEN
# of Institutions
22Shares Held
6.37MCall Options Held
0Put Options Held
0-
Pendal Group LTD4.3MShares$198 Million1.76% of portfolio
-
Abeille Asset Management Sa931KShares$42.8 Million1.68% of portfolio
-
Grandeur Peak Global Advisors, LLC Salt Lake City, UT796KShares$36.6 Million3.21% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8153KShares$7.05 Million0.01% of portfolio
-
Bdl Capital Management Paris, I088.8KShares$4.08 Million3.33% of portfolio
About QIAGEN N.V.
- Ticker QGEN
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 227,694,000
- Market Cap $10.5B
- Description
- QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...